Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-09-11
2007-09-11
Seaman, Margaret D. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S126000, C544S127000
Reexamination Certificate
active
11130669
ABSTRACT:
Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.
REFERENCES:
patent: 5707798 (1998-01-01), Brann
patent: 6670386 (2003-12-01), Sun et al.
patent: 2004/0181064 (2004-09-01), Sun et al.
patent: 1553 074 (2005-07-01), None
patent: 308 897 (1989-03-01), None
patent: WO 2003/011824 (2003-02-01), None
patent: WO 2003/096980 (2003-11-01), None
patent: WO 2004/016576 (2004-02-01), None
patent: 2005/090282 (2005-09-01), None
Kashman et al., Tetrahedron, “Circular dichroism of heterocyclohexan-4-onic systems-II”, 1972, vol. 28, pp. 155-165.
Alm et al.,Prog. Clin. Biol. Res., 312:447-58 (1989).
Alterman and Hallberg (J. Org. Chem., 2000, 65, 7984-7989).
Antilla & Buchwald,Org. Lett., 2001, 3, 2077-2079.
Arvela & Leadbeater,J. Org. Chem, 2003, 68, 9122-9125.
Bassilios et al,Recueil., 1962, 81, 209-214.
“Bioreversible Carriers in Drug Design: Theory and Application”, edited by E. B. Roche, Pergamon Press: New York, 14-21 (1987).
Brown & Reid,J. Am. Chem. Soc., 1924, 46, 1838.
Buchwald et al,J. Am. Chem. Soc., 2002, 124, 7421-7428.
Buchwald et al,Org. Lett., 2002, 4, 581-584.
Bun-Hoi et al,J. Org. Chem., 1951, 16, 988.
Bundgaard, H. et al.,J. Med. Chem., 32, 2503-2507 (1989).
Cacchi et al,Org. Lett, 2003, 5, 289-293.
Cacchi et al,Org. Lett, 2003, 5, 4269-4293.
Cakmak O. et al.,Collect. Czech. Chem. Commun.2000, 65, 1791-1804.
Consden & Kenyon,J. Chem. Soc., 1935, 1591-1596.
Davies H. M. L. et al.,J. Org. Chem.1991, 56, 5696-5700.
Dewar et al.,J. Am. Chem. Soc., 1962, 84, 3541-3546.
Emerson & Walters,J. Am. Chem. Soc., 1938, 60, 2023.
Fingl et al. 1975, in “The Pharmacological Basis of Therapeutics”.
Frost & Wadsworth,Chem. Commun., 2001, 22, 2316-2317.
G. Schiemann et al.,Ann., 1931, 487, 270-287.
Greene & Wuts,Protective Groups in Organic Synthesis, John Wiley & Sons, 1991.
Guthrie et al,Can. J. Chem., 1993, 71, 2109-2122.
Hartwig,Angew. Chem. Int. Ed., 1998, 37, 2046-2067.
Hartwig inModern Amination Methods; Ricci, Ed.; Willey-VCH: Weinheim, Germany, 2000.
Hirst & Cohen,J. Chem. Soc., 1895, 67, 830.
Joshi, A.,J. Ocul. Pharmacol., 10(1):29-45 (1994).
Klitgaard, N. et al., Acta Chem. Scand. 1970, 24, 33-42.
Kwong & Buchwald,Org. Lett., 2003, 5, 793-796.
Kwong & Buchwald,Org. Lett., 2002, 4, 3517-3520.
L. Paquette, ed.,Encyclopedia of Reagents for Organic Synthesis, John Wiley and Sons, 1995.
Landini & Rocca, Synthesis, 1974, 565-566.
Li,J. Org. Chem., 2002, 67, 3643-3650.
Mahfous, N.H. et al,J. Pharm. Pharmacol., 53, 841-848 (2001).
Mayer et al.,Ophthamologica, 210(2):101-3 (1996).
Milovic et al,Synthesis, 1991, 11, 1043-1045.
Mordenti,Toxicol. Sci., 52(1):101-6 (1999).
Nigam & Weedon,J. Chem. Soc., 1957, 200.
Olah & Kuhn,Chem. Ber.1956, 89, 2211.
Protective Groups in Organic Chemistry(ed. J.F.W. McOmie, Plenum Press, 1973).
R. Larock,Comprehensive Organic Transformations, VCH Publishers, 1989.
Read,J. Am. Chem. Soc., 1922, 44, 1746-1755.
Remington's Pharmaceutical Sciences, 18th Ed., Mack Publishing Co., Easton, PA (1990).
Rice & Kohn,J. Am. Chem. Soc., 1955, 77, 4052.
S. Sekiguchi et al.,J. Org. Chem., 1979, 44, 3921-3925.
Screttas and Micha-Screttas,J. Org. Chem., 1978, 43, 1064-1071.
Shedden et al.,Clin. Ther., 23(3):440-50 (2001).
Sundermeier et al,Angew. Chem. Int. ed., 2003, 42, 1661-1664.
T. Higuchi and V. Stella, in “Prodrugs as Novel Delivery Systems”, vol. 14, A.C.S. Symposium Series, American Chemical Society (1975).
T. Wang et al.,Org. Lett., 2003, 5, 897-900.
Vogel,J. Chem. Soc., 1948, 1809.
W. Adcock et al.,J. Am. Chem. Soc., 1967, 89, 386-390.
Wan et al,J. Org. Chem., 202, 67, 6232-6235.
Whitmore and Lester,J. Am. Chem. Soc., 1942, 64, 1247.
Whitmore et al,J. Am. Chem. Soc., 1947, 69, 235-237.
Wolf,Liebigs Ann. Chem., 1952, 576, 35.
Wolfe and BuchwaldTetrahedron Lett., 1997, 37, 6359-6362.
Gooβen and Ghosh,Angew. Chem. Int. Ed. Engl., 2001, 40, 3458-3460.
Yasukara et al,J. Chem. Soc. Perkin Trans. 1, 2000, 17, 2901-2902.
Yang & Buchwald,J. Organometallic Chem., 1999, 576, 125-146.
Yang and Denny,J. Org. Chem., 2002, 67, 8958-8961.
Yin & Buchwald,J. Am. Chem. Soc., 2002, 124, 6043-6048.
International Search Report for corresponding PCT Application No. PCT/US2005/017143, mailed on Nov. 30, 2005.
International Written Opinion for corresponding PCT Application No. PCT/US2005/017143, mailed on Nov. 30, 2005.
Badalassi Fabrizio
Fejzic Alma
Lewinsky Rasmus
Lund Birgitte Winther
Olsson Roger
Acadia Pharmaceuticals Inc.
Rahmani Niloofar
Seaman Margaret D.
Wilson Sonsini Goodrich & Rosati
LandOfFree
Androgen receptor modulators and method of treating disease... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Androgen receptor modulators and method of treating disease..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Androgen receptor modulators and method of treating disease... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3725239